A detailed history of Fulcrum Capital LLC transactions in Dexcom Inc stock. As of the latest transaction made, Fulcrum Capital LLC holds 37,881 shares of DXCM stock, worth $3.04 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
37,881
Previous 34,072 11.18%
Holding current value
$3.04 Million
Previous $2.33 Million 42.13%
% of portfolio
0.72%
Previous 0.53%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025

BUY
$59.83 - $87.57 $227,892 - $333,554
3,809 Added 11.18%
37,881 $3.31 Million
Q1 2025

Apr 08, 2025

BUY
$67.74 - $90.75 $2.31 Million - $3.09 Million
34,072 New
34,072 $2.33 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Fulcrum Capital LLC Portfolio

Follow Fulcrum Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.